Triple-Drug Graft-versus-Host Disease Prophylaxis after HLA-Matched Unrelated Donor Nonmyeloablative Allogenic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Triple-Drug Graft-versus-Host Disease Prophylaxis after HLA-Matched Unrelated Donor Nonmyeloablative Allogenic Hematopoietic Stem Cell Transplantation

Published:2023-09 Issue:9 Volume:29 Page:575.e1-575.e6
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Wegener Alma^ORCID,Andersen Niels Smedegaard,Friis Lone Smidstrup,Petersen Søren Lykke,Schjødt Ida,Kornblit Brian,Sengeløv Henrik,Gjærde Lars Klingen^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference37 articles.

1. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects;McSweeney;Blood,2001

2. Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation;Storb;J Clin Oncol,2013

3. Hematopoietic stem-cell transplantation;Copelan;N Engl J Med,2006

4. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial;Sandmaier;Lancet Haematol,2019

5. Interpretation and impact of real-world clinical data for the practicing clinician;Blonde;Adv Ther,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the regulatory mechanisms of mTOR in necroptosis;Frontiers in Immunology;2023-12-18